Cordyceps Sunshine Biotech Holdings (RAJAF) Work In Process (2020 - 2022)

Cordyceps Sunshine Biotech Holdings' Work In Process history runs 3 years deep, the most recent figure standing at $266488.0 for Q4 2022.

• In Q4 2022, Work In Process fell 31.77% year-over-year to $266488.0; the TTM figure through Dec 2022 stood at $266488.0 (down 31.77% YoY), while the FY2022 annual figure was $266488.0, down 31.77% from the prior year.
• Work In Process was $266488.0 for Q4 2022 at Cordyceps Sunshine Biotech Holdings, down from $390588.0 in the prior quarter.
• In the past five years, Work In Process ranged from a high of $665082.0 in Q4 2020 to a low of $266488.0 in Q4 2022.
• Historically, Work In Process has averaged $440719.3 across 3 years, with a median of $390588.0 in 2021.
• The sharpest annual moves came in 2021 and 2022: Work In Process slumped 41.27% in 2021, then plunged 31.77% in 2022.
• A 3-year view of Work In Process shows it stood at $665082.0 in 2020, then plunged by 41.27% to $390588.0 in 2021, then slumped by 31.77% to $266488.0 in 2022.
• The last three Work In Process figures came in at $266488.0 (Q4 2022), $390588.0 (Q4 2021), and $665082.0 (Q4 2020), per Business Quant data.